文献
J-GLOBAL ID:201702281848090293
整理番号:17A1159331
膵臓癌における代謝調節による化学療法効果を増強するための新規NQO1生理活性可能薬,β-ラパコン(ARQ761)を用いた【Powered by NICT】
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer
著者 (19件):
Beg Muhammad Shaalan
(Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Beg Muhammad Shaalan
(Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Huang Xiumei
(Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Huang Xiumei
(Departments of Pharmacology and Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Silvers Molly A.
(Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Gerber David E.
(Division of Hematology and Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Gerber David E.
(Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Bolluyt Joyce
(Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Sarode Venetia
(Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Sarode Venetia
(Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Fattah Farjana
(Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Deberardinis Ralph J.
(Departments of Pharmacology and Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Deberardinis Ralph J.
(Children‘s Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Merritt Matthew E.
(Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida)
,
Xie Xian-Jin
(Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Leff Richard
(Clinical Pharmacology & Experimental Therapeutics Center, Texas Tech University Health Sciences Center, School of Pharmacy, Dallas, Texas)
,
Laheru Daniel
(Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland)
,
Boothman David A.
(Harold Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas)
,
Boothman David A.
(Departments of Pharmacology and Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas)
資料名:
Journal of Surgical Oncology
(Journal of Surgical Oncology)
巻:
116
号:
1
ページ:
83-88
発行年:
2017年
JST資料番号:
W2664A
ISSN:
0022-4790
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)